Mice that are re-challenged with chromosomally stable CD47 KO tumors (and without exogenous anti-Tyrp1 opsonization) show increased median survival and increased immune infiltrate, further supporting the hypothesis of newly generated anti-cancer acquired immunity. Here, TYRP1 is linked to cancer.